WILLIAM R RINGO

CIK 1238325 · Chief Executive Officer · last filed 2025-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.79M

Companies

12

Total Filings

153

Lifetime Open-Market Net

-$4.32M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ASMB Director 1,455 $27.12 $39.5K -$510.4K 23 2025-06-09
Sensei Biotherapeutics, Inc. (SNSE) Delisted Director 1,170 $13.85 $16.2K $0 4 2025-05-23
FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted Chief Executive Officer 0 $38.00 $0 -$1.78M 14 2021-04-19
DERM Director 6,000 $6.42 $38.5K -$165.7K 17 2019-06-14
FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted Director 10,000 $178.75 $1.79M -$374.3K 16 2019-06-12
SANGAMO THERAPEUTICS, INC (SGMO) Delisted Director 31,800 $0.18 $5.6K -$1.10M 15 2017-09-22
Mirati Therapeutics, Inc. (MRTX) Delisted Director $58.70 $0 4 2016-05-19
ASSEMBLY BIOSCIENCES, INC. (VTUS) Delisted Director 20,465 $0 1 2014-07-14
ONYX PHARMACEUTICALS INC (ONXX) Delisted Director 9,837 -$400.3K 7 2013-04-01
PFE Senior Vice President 255,139 $26.30 $6.71M $0 37 2010-04-01
ALLOS THERAPEUTICS INC (ALTH) Delisted Director 3,000 $0 2 2007-06-21
INSPIRE PHARMACEUTICALS INC (ISPH) Delisted Director $0 1 2007-06-12

Recent Filings · Page 7 of 16

153 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-01-06 Grant (A) $0
2017-01-04 DERM Mixed -$8.0K EDGAR
2017-01-03 FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted Mixed -$19.7K EDGAR
2016-12-16 DERM Mixed -$2.0K EDGAR
2016-12-02 DERM Mixed -$6.0K EDGAR
2016-12-02 FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted Mixed -$23.0K EDGAR
2016-11-10 DERM Mixed -$8.1K EDGAR
2016-11-02 FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted Mixed -$18.5K EDGAR
2016-10-04 DERM Mixed -$9.1K EDGAR
2016-10-04 FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted Mixed -$20.2K EDGAR
Showing 6170 of 153
Page 7 of 16
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.